Abstract
BACKGROUND: One of the common and alarming problems to the patients is keloid formation that may occur after skin injury. Keloid had many cosmetic psychological and functional outcome, Multiple treatment have been present but still the treatment of keloid scar is dilemma due to lack of effective and excellent method . AIM OF STUDY:To evaluate the use of intralesional BTX-A for treatment of keloid scar.PATIENTS AND METHODS: Between October 2018 to January 2020, 20 patients presented to us with history of keloid in different parts of their body, those patients received intralesional BTX-A injection and they were followed up for one year and evaluated by scar score system.RESULTS: Our result showed that 10 patients had good response according to scar score, 7 patients had fair, 1 excellent and 2 patient had no improvement.no local and systemic side effect was seen.CONCLUSION: The use of BTX-A for treatment of keloids has shown to be effective in control and treatment of keloid and can be a part of treatment modalities
Recommended Citation
Shaheed, Rusul and Arajy, Zakaria
(2023)
"Evaluation of Botulonium Toxin Type A in the Management of Keloid Scar,"
Iraqi Postgraduate Medical Journal: Vol. 22:
Iss.
1, Article 5.
DOI: 10.52573/ipmj.2023.179188
Available at:
https://ipmj.researchcommons.org/journal/vol22/iss1/5
DOI
10.52573/ipmj.2023.179188